{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:23:14Z","timestamp":1793467394083,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.lungcan.2025.108458","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T11:02:18Z","timestamp":1740826938000},"page":"108458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Prevalence and prognostic significance of interstitial lung abnormalities in lung cancer: A meta-analysis"],"prefix":"10.1016","volume":"205","author":[{"given":"Ruiyuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0985-0311","authenticated-orcid":false,"given":"Weimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lungcan.2025.108458_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108458_b0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108458_b0015","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.lungcan.2025.108458_b0020","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.chest.2016.02.650","article-title":"Evaluation of pulmonary nodules: clinical practice consensus guidelines for asia","volume":"150","author":"Bai","year":"2016","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.lungcan.2025.108458_b0025","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/thoraxjnl-2016-209825","article-title":"Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial","volume":"72","author":"Paci","year":"2017","journal-title":"Thorax"},{"issue":"10374","key":"10.1016\/j.lungcan.2025.108458_b0030","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0140-6736(22)01694-4","article-title":"Lung cancer screening","volume":"401","author":"Adams","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108458_b0035","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1183\/09031936.00201809","article-title":"Interstitial lung diseases in a lung cancer screening trial","volume":"38","author":"Sverzellati","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108458_b0040","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1148\/rg.220073","article-title":"Interstitial lung abnormalities at CT: subtypes, clinical significance, and associations with lung cancer","volume":"42","author":"Hata","year":"2022","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.lungcan.2025.108458_b0045","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00533-2023","article-title":"ERS\/ESTS\/ESTRO\/ESR\/ESTI\/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer","volume":"62","author":"O'Dowd","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.lungcan.2025.108458_b0050","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJMoa1007285","article-title":"Lung volumes and emphysema in smokers with interstitial lung abnormalities","volume":"364","author":"Washko","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108458_b0055","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S2213-2600(20)30168-5","article-title":"Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society","volume":"8","author":"Hatabu","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108458_b0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1148\/radiol.2021204367","article-title":"Interstitial lung abnormalities: state of the art","volume":"301","author":"Hata","year":"2021","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.lungcan.2025.108458_b0065","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1136\/thorax-2022-219068","article-title":"Lung cancer screening provides an opportunity for early diagnosis and treatment of interstitial lung disease","volume":"77","author":"Hewitt","year":"2022","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.lungcan.2025.108458_b0070","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1164\/rccm.202302-0271OC","article-title":"Prevalence, risk factors, and outcomes of adult interstitial lung abnormalities: a systematic review and meta-analysis","volume":"208","author":"Grant-Orser","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108458_b0075","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S2213-2600(20)30168-5","article-title":"Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society","volume":"8","author":"Hatabu","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"7818","key":"10.1016\/j.lungcan.2025.108458_b0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41586-020-2481-8","article-title":"The National Lung Matrix Trial of personalized therapy in lung cancer","volume":"583","author":"Middleton","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2025.108458_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.lungcan.2025.108458_b0090","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"issue":"24","key":"10.1016\/j.lungcan.2025.108458_b0095","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Stat. Med."},{"key":"10.1016\/j.lungcan.2025.108458_b0100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.lungcan.2025.108458_b0105","unstructured":"B.S. GA Wells, D. O'Connell, J. Peterson, V. Welch, M. Losos, P. Tugwell, The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Accessed 2022\/09\/22, 2022. https:\/\/www.ohri.ca\/\/programs\/clinical_epidemiology\/oxford.asp."},{"issue":"11","key":"10.1016\/j.lungcan.2025.108458_b0110","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/jech-2013-203104","article-title":"Meta-analysis of prevalence","volume":"67","author":"Barendregt","year":"2013","journal-title":"J. Epidemiol. Commun. Health"},{"key":"10.1016\/j.lungcan.2025.108458_b0115","doi-asserted-by":"crossref","unstructured":"J.P. Higgins, S. Green, Cochrane handbook for systematic reviews of interventions, 2008.","DOI":"10.1002\/9780470712184"},{"issue":"13","key":"10.1016\/j.lungcan.2025.108458_b0120","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jacc.2011.06.024","article-title":"Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies","volume":"58","author":"Dong","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7109","key":"10.1016\/j.lungcan.2025.108458_b0125","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108458_b0130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"issue":"5","key":"10.1016\/j.lungcan.2025.108458_b0135","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ejrad.2015.01.021","article-title":"Interstitial lung abnormalities in treatment-na\u00efve advanced non-small-cell lung cancer patients are associated with shorter survival","volume":"84","author":"Nishino","year":"2015","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.lungcan.2025.108458_b0140","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejro.2019.03.003","article-title":"Interstitial lung abnormality in stage IV non-small cell lung cancer: a validation study for the association with poor clinical outcome","volume":"6","author":"Araki","year":"2019","journal-title":"Eur. J. Radiol. Open"},{"issue":"6","key":"10.1016\/j.lungcan.2025.108458_b0145","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.21037\/tlcr-20-1050","article-title":"Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease","volume":"9","author":"Liu","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108458_b0150","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/thoraxjnl-2021-218055","article-title":"Impact of interstitial lung abnormalities on postoperative pulmonary complications and survival of lung cancer","volume":"78","author":"Im","year":"2023","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108458_b0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40644-021-00383-w","article-title":"Interstitial lung abnormalities in patients with stage I non-small cell lung cancer are associated with shorter overall survival: the Boston lung cancer study","volume":"21","author":"Hida","year":"2021","journal-title":"Cancer Imaging"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108458_b0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13014-021-01780-y","article-title":"Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities","volume":"16","author":"Kobayashi","year":"2021","journal-title":"Radiat. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108458_b0165","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/1759-7714.14341","article-title":"Clinical implication of interstitial lung abnormality in elderly patients with early-stage non-small cell lung cancer","volume":"13","author":"Cho","year":"2022","journal-title":"Thorac Cancer"},{"issue":"24","key":"10.1016\/j.lungcan.2025.108458_b0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/cancers14246236","article-title":"Pre-existing interstitial lung abnormalities are independent risk factors for interstitial lung disease during durvalumab treatment after chemoradiotherapy in patients with locally advanced non-small-cell lung cancer","volume":"14","author":"Daido","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.lungcan.2025.108458_b0175","doi-asserted-by":"crossref","first-page":"744","DOI":"10.4143\/crt.2021.772","article-title":"Predictive value of interstitial lung abnormalities for postoperative pulmonary complications in elderly patients with early-stage lung cancer","volume":"54","author":"Jeong","year":"2022","journal-title":"Cancer Res. Treat."},{"issue":"20","key":"10.1016\/j.lungcan.2025.108458_b0180","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1002\/cam4.4750","article-title":"Impact of pre-existing interstitial lung abnormal shadow on lung injury development and severity in patients of non-small cell lung cancer treated with osimertinib","volume":"11","author":"Shibaki","year":"2022","journal-title":"Cancer Med."},{"issue":"11","key":"10.1016\/j.lungcan.2025.108458_b0185","doi-asserted-by":"crossref","first-page":"8251","DOI":"10.1007\/s00330-023-09783-x","article-title":"Automated CT quantification of interstitial lung abnormality and interstitial lung disease according to the Fleischner Society in patients with resectable lung cancer: prognostic significance","volume":"33","author":"Ahn","year":"2023","journal-title":"Eur. Radiol."},{"issue":"10","key":"10.1016\/j.lungcan.2025.108458_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20463","article-title":"Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer","volume":"9","author":"Fukuda","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108458_b0195","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1093\/oncolo\/oyad187","article-title":"Pre-existing interstitial lung abnormalities and immune checkpoint inhibitor-related pneumonitis in solid tumors: a retrospective analysis","volume":"29","author":"Horiuchi","year":"2024","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108458_b0200","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2478\/raon-2023-0018","article-title":"Subpleural fibrotic interstitial lung abnormalities are implicated in non-small cell lung cancer radiotherapy outcomes","volume":"57","author":"Ito","year":"2023","journal-title":"Radiol. Oncol."},{"issue":"1148","key":"10.1016\/j.lungcan.2025.108458_b0205","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20220812","article-title":"Survival impact of fibrotic interstitial lung abnormalities in resected stage IA non-small cell lung cancer","volume":"96","author":"Jeong","year":"2023","journal-title":"Br. J. Radiol."},{"issue":"4","key":"10.1016\/j.lungcan.2025.108458_b0210","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.21873\/anticanres.16333","article-title":"Effect of interstitial lung abnormality on concurrent chemoradiotherapy-treated stage III non-small cell lung cancer patients","volume":"43","author":"Jeong","year":"2023","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108458_b0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/1759-7714.14718","article-title":"Clinical significance of interstitial lung abnormalities and immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer","volume":"14","author":"Murata","year":"2023","journal-title":"Thorac Cancer."},{"issue":"8","key":"10.1016\/j.lungcan.2025.108458_b0220","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cllc.2023.08.014","article-title":"Impact of baseline interstitial lung abnormalities on pneumonitis risk in patients receiving immune checkpoint inhibitors for non-small-cell lung cancer","volume":"24","author":"Petranovic","year":"2023","journal-title":"Clin. Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2025.108458_b0225","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12885-024-12008-z","article-title":"Quantification of preexisting lung ground glass opacities on CT for predicting checkpoint inhibitor pneumonitis in advanced non-small cell lung cancer patients","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2025.108458_b0230","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/jjco\/hyz016","article-title":"Chemoradiotherapy for locally advanced lung cancer patients with interstitial lung abnormalities","volume":"49","author":"Higo","year":"2019","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2025.108458_b0235","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.resinv.2019.05.002","article-title":"Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer","volume":"57","author":"Nakanishi","year":"2019","journal-title":"Respir. Investig."},{"issue":"19","key":"10.1016\/j.lungcan.2025.108458_b0240","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/1759-7714.14935","article-title":"Newly diagnosed non-small cell lung cancer with interstitial lung abnormality: prevalence, characteristics, and prognosis","volume":"14","author":"Zhu","year":"2023","journal-title":"Thorac. Cancer"},{"issue":"16","key":"10.1016\/j.lungcan.2025.108458_b0245","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/1759-7714.15306","article-title":"Automated CT quantification of interstitial lung abnormality in patients with resectable stage I non-small cell lung cancer: prognostic significance","volume":"15","author":"Chung","year":"2024","journal-title":"Thorac. Cancer"},{"issue":"11","key":"10.1016\/j.lungcan.2025.108458_b0250","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2023.7059","article-title":"Association between pretreatment chest imaging and immune checkpoint inhibitor pneumonitis among patients with lung cancer","volume":"21","author":"Wong","year":"2023","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108458_b0255","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.2016.0518","article-title":"Association between interstitial lung abnormalities and all-cause mortality","volume":"315","author":"Putman","year":"2016","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108458_b0260","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1038\/s41598-024-57831-3","article-title":"Clinical outcomes of interstitial lung abnormalities: a systematic review and meta-analysis","volume":"14","author":"Seok","year":"2024","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.lungcan.2025.108458_b0265","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1200\/JCO.2009.24.5050","article-title":"Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105","volume":"28","author":"Yamamoto","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108458_b0270","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/1759-7714.14341","article-title":"Clinical implication of interstitial lung abnormality in elderly patients with early-stage non-small cell lung cancer","volume":"13","author":"Cho","year":"2022","journal-title":"Thorac. Cancer"},{"issue":"8","key":"10.1016\/j.lungcan.2025.108458_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.cllc.2023.08.014","article-title":"Impact of baseline interstitial lung abnormalities on pneumonitis risk in patients receiving immune checkpoint inhibitors for non-small-cell lung cancer","volume":"24","author":"Petranovic","year":"2023","journal-title":"Clin. Lung Cancer"},{"issue":"8","key":"10.1016\/j.lungcan.2025.108458_b0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202360","article-title":"Lung cancer in idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"13","author":"JafariNezhad","year":"2018","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.lungcan.2025.108458_b0285","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1513\/AnnalsATS.201807-481OC","article-title":"Idiopathic pulmonary fibrosis and lung cancer. A systematic review and meta-analysis","volume":"16","author":"Brown","year":"2019","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"11","key":"10.1016\/j.lungcan.2025.108458_b0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259784","article-title":"Impact of concomitant idiopathic pulmonary fibrosis on prognosis in lung cancer patients: a meta-analysis","volume":"16","author":"Wang","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lungcan.2025.108458_b0295","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.chest.2021.12.656","article-title":"Clinical outcomes of immune checkpoint inhibitor therapy in patients with advanced non-small cell lung cancer and preexisting interstitial lung diseases: a systematic review and meta-analysis","volume":"161","author":"Zhang","year":"2022","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.lungcan.2025.108458_b0300","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1164\/rccm.201512-2523OC","article-title":"Development and progression of interstitial lung abnormalities in the framingham heart study","volume":"194","author":"Araki","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.lungcan.2025.108458_b0305","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1164\/rccm.201607-1363ED","article-title":"Subclinical interstitial lung abnormalities: toward the early detection of idiopathic pulmonary fibrosis?","volume":"194","author":"Wells","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.lungcan.2025.108458_b0310","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s00330-021-08378-8","article-title":"Radiologic-pathologic correlation of interstitial lung abnormalities and predictors for progression and survival","volume":"32","author":"Chae","year":"2022","journal-title":"Eur. Radiol."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108458_b0315","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1148\/radiol.2019182466","article-title":"Computer-aided quantification of pulmonary fibrosis in patients with lung cancer: relationship to disease-free survival","volume":"292","author":"Iwasawa","year":"2019","journal-title":"Radiology"},{"issue":"129","key":"10.1016\/j.lungcan.2025.108458_b0320","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1183\/09059180.00003613","article-title":"Common pathways in idiopathic pulmonary fibrosis and cancer","volume":"22","author":"Vancheri","year":"2013","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.lungcan.2025.108458_b0325","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.addr.2017.07.010","article-title":"Drug targeting to myofibroblasts: implications for fibrosis and cancer","volume":"121","author":"Yazdani","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108458_b0330","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12931-023-02536-w","article-title":"Bronchial epithelial gene expression and interstitial lung abnormalities","volume":"24","author":"Menon","year":"2023","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108458_b0335","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","article-title":"A CXCL1 paracrine network links cancer chemoresistance and metastasis","volume":"150","author":"Acharyya","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2025.108458_b0340","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.656908","article-title":"The role of tumor necrosis factor in manipulating the immunological response of tumor microenvironment","volume":"12","author":"Laha","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lungcan.2025.108458_b0345","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1038\/s41467-022-33719-6","article-title":"Phase I trial of the TNF-\u03b1 inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas","volume":"13","author":"Paik","year":"2022","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.lungcan.2025.108458_b0350","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1164\/rccm.201903-0511OC","article-title":"Overlap of genetic risk between interstitial lung abnormalities and idiopathic pulmonary fibrosis","volume":"200","author":"Hobbs","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108458_b0355","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tranon.2016.12.009","article-title":"The Pulmonary fibrosis associated MUC5B promoter polymorphism is prognostic of the overall survival in patients with non-small cell lung cancer (NSCLC) receiving definitive radiotherapy","volume":"10","author":"Yang","year":"2017","journal-title":"Transl. Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225000790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225000790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T14:50:30Z","timestamp":1752591030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500225000790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":71,"alternative-id":["S0169500225000790"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108458","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and prognostic significance of interstitial lung abnormalities in lung cancer: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108458"}}